Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)
Information source: Georgia Regents University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cardiovascular Disease
Intervention: Antioxidant cocktail (Dietary Supplement); Biopsy (Other); Placebo (Other); NMD; 0.4mg sub-lingual nitroglycerin spray (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: Georgia Regents University Official(s) and/or principal investigator(s): Ryan Harris, PhD, Principal Investigator, Affiliation: Georgia Regents University
Overall contact: Ryan Harris, PhD, Phone: 706 721-5998, Email: ryharris@gru.edu
Summary
Cardiovascular disease is the leading cause of death in the United States. Other studies
have shown that stress, early in life, could be a risk factor for cardiovascular disease,
later in life. This study will look at the effect of early life stressors on your
cardiovascular health.
Clinical Details
Official title: Effect of Low Childhood Socioeconomic Status (SES) on Adult Endothelial Function and Nitric Oxide Bioavailability in Vivo and ex Vivo
Study design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Primary outcome: Acute Change in Flow mediated dilationAcute Change in Flow mediated dilation
Secondary outcome: Acute Change in Biomarkers of oxidative stressAcute Change in Arterial Stiffness Acute change in Flow mediated dilation
Detailed description:
This study will have two parts involved to investigate the role that childhood SES status
has on cardiovascular health.
Part one: Subjects will give a blood sample which will be processed and analyzed. Flow
mediated dilation (FMD) and Pulse wave velocity (PWV/PWA) will be performed at baseline and
2 hours following either a single dose oral antioxidant cocktail (1000 mg of Vitamin C, 600
IU of Vitamin E, and 600 mg of alpha-lipoic acid) or placebo on two days separated by at
least 72 hours. Nitroglycerin mediated dilation (NMD, 0. 4mg sub-lingual nitroglycerin
spray), will be assessed at baseline.
Part two: Subjects, if interested will undergo a subcutaneous gluteal/hip fat biopsy. Micro
vessels will be isolated from the adipose tissue and analyzed by pressurized myography for
endothelial function and nitric oxide bioavailability.
Eligibility
Minimum age: 18 Years.
Maximum age: 40 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- documented childhood SES
- men and premenopausal women ages 18-40
- lean/overweight/or obese with BMI< or equal to 39kg/m2
Exclusion Criteria:
- cardiovascular, renal, pulmonary, hepatic, cerebral, or metabolic,disease
- use medications that affect vascular tone
- post menopausal women
- have class 3 obesity or BMI over 40
Locations and Contacts
Ryan Harris, PhD, Phone: 706 721-5998, Email: ryharris@gru.edu
Georgia Prevention Institute , Georgia Regents University, Augusta, Georgia 30912, United States; Recruiting Ryan Harris, PhD, Phone: 706-721-5998, Email: ryharris@gru.edu Jacqueline Musall, BS, Phone: 706 721-8515, Email: jmusall@gru.edu Ryan Harris, PhD, Principal Investigator
Additional Information
Starting date: April 2014
Last updated: July 17, 2015
|